Eye Injections and Eye Pressure at a Glance
If you have had many eye injections, this is a fair thing to ask. The short answer is measured. Anti-VEGF eye injections can raise the pressure inside the eye. For most people the rise is small and brief. In a smaller group, the pressure creeps up and stays up over many shots. Across many studies, a lasting rise in eye pressure showed up in about 5 of every 100 eyes given repeated anti-VEGF injections.1 A lasting high pressure can act like glaucoma and slowly harm the optic nerve if no one treats it. The good news is that your eye team can watch for this and treat it, and most people keep getting the injections their retina needs.
There are two very different pressure changes, and mixing them up causes a lot of worry. The first is a quick spike right after the needle goes in, because a little more fluid is now inside a closed eye. This brief spike is short-lived and usually settles back to normal on its own within about an hour, with no pressure-lowering drug needed.2 The second is a slow, sustained rise that can build up over many injections and does not go away by itself. That second kind is the one your doctor tracks over time, and it is the reason your pressure is checked at your visits.
The tricky part is that a sustained pressure rise rarely feels like anything. Higher eye pressure and early glaucoma usually cause no symptoms, which is why about half of people who have glaucoma do not know they have it.3 You cannot feel your pressure, so you cannot rely on how your eye feels to catch a problem. That is the whole point of the pressure check your team does at your appointments. It lets them spot a rise early, while it is easy to treat, long before it could ever threaten your sight.
What Eye Pressure Is and How Injections Can Raise It
Your eye is a firm, fluid-filled ball. It constantly makes a clear liquid inside the front of the eye and drains that liquid out through a tiny mesh-like filter. The balance between what is made and what drains sets the pressure inside your eye, measured in units called mmHg. When the filter drains too slowly, pressure builds. Glaucoma is a group of eye diseases that damage the optic nerve, the cable that carries sight to the brain, and it is often linked to eye pressure that is too high; lowering the pressure helps protect the nerve.3 So 'eye pressure' and 'glaucoma' are related but not the same. High pressure is a risk to the nerve, and glaucoma is the nerve damage itself.
Anti-VEGF injections are a retina treatment given as a shot into the jelly of the eye. They calm down leaky, overgrown blood vessels at the back of the eye. These injections are used to treat retinal conditions such as wet (neovascular) age-related macular degeneration, diabetic macular edema, diabetic retinopathy, and retinal vein occlusion.4 Common examples of these medicines include bevacizumab (Avastin), ranibizumab (Lucentis), and aflibercept (Eylea). A few anti-VEGF medicines are used off-label, an accepted practice where a drug is given for a condition not listed on its official label. Because these conditions come back if untreated, many people need a series of injections over months or years, which is how the injection count climbs into the dozens.
The most basic reason pressure rises is simple volume. The eye is a sealed space, so adding even a small amount of medicine raises the pressure for a while, the way blowing more air into a ball makes it firmer. During an injection the eye's pressure can rise for a short time, and the doctor may take a step to bring it back down before you leave.4 This immediate effect is normal and expected. For nearly everyone it is temporary. It becomes worth watching only when the pressure does not come back down as it should, or when it starts to sit high between visits.
Why Repeated Injections Can Raise Eye Pressure Over Time
Right after the shot, the pressure inside the eye can jump up sharply for a few minutes. This is the volume effect, and it is usually harmless. The rise after an injection is short-lived and returns to the normal range within about half an hour to an hour in nearly all patients, without any pressure-lowering medicine.2 Your doctor knows this spike happens and may check the pressure or the blood flow at the back of the eye before you go. If a spike is unusually high, there are quick ways to relieve it in the office. On its own, this brief spike is not thought to cause lasting harm in most eyes.
The kind that needs real attention is a pressure that stays up over a long series of injections. Researchers are still sorting out exactly why this happens in some eyes. Proposed reasons include the strain of many repeated short spikes, tiny protein particles or bits from the medicine partly clogging the eye's drainage mesh, and low-grade inflammation, especially in eyes whose drainage was already working near its limit.1 In other words, the eye's outflow filter slowly falls behind. This is why the risk is not a one-time event but something that can grow across a long treatment course, and why long-treated patients ask about it.
It helps to know that not all eye injections behave the same way. Steroid injections, sometimes used for swelling at the back of the eye, raise pressure through a different route and do so far more often than anti-VEGF shots. In one large study, about 20 of every 100 people given steroid eye injections were found to have glaucoma or high eye pressure within 5 years, a higher rate than seen after anti-VEGF injections.5 So if a friend on steroid injections had a pressure problem, that does not mean your anti-VEGF shots carry the same odds. If you get both types, tell your team, because the steroid is the bigger pressure risk.
Some people start with more room to spare than others. A history of glaucoma or already-high eye pressure raises the chance of a sustained pressure rise from anti-VEGF injections, and the risk also tends to climb with more injections over time.1 An eye whose drainage is already borderline has less cushion when injections are added. None of this means you should not have the injections. It means your team may watch your pressure more closely, space the shots where they can, or start a pressure-lowering drop early if your numbers drift up.
The Symptoms to Know, and Why There Usually Are None
The hardest thing about a slow pressure rise is that it hides. It does not usually hurt, blur your vision, or turn your eye red. Because early glaucoma and higher pressure typically produce no warning signs at all, the damage can begin before a person notices anything is wrong.3 By the time side vision is clearly missing, a fair amount of nerve has often been lost, and that loss does not come back. This is not meant to frighten you. It is the reason the quiet, routine pressure check at your injection visits does so much of the protective work here.
There is one situation where high pressure does announce itself. If the pressure spikes very high right after an injection and does not settle, the eye can become genuinely painful, hard, and sensitive to light, sometimes with blurred vision. This is uncommon, but it is worth knowing, because it is a reason to be seen the same day rather than to wait it out. A big, painful spike and a serious eye infection can feel similar in the first hours, and both need prompt care. The warning-signs section below spells out exactly what those danger signs are.
How Your Eye Team Checks and Diagnoses a Pressure Problem
The main tool is simple and fast. At your appointments, a technician or doctor measures the pressure in each eye with a quick, painless test that takes seconds. Tracking that number visit after visit is powerful, because a single reading matters less than the trend over time and how it compares with your own past numbers. If your pressure starts drifting up across several visits, that pattern is the early signal your team is watching for, and it can prompt a closer look well before any damage would occur.
Pressure is only half the picture; the health of the optic nerve is the other half. Doctors check for glaucoma with a dilated eye exam that lets them look directly at the optic nerve, along with a visual field test that maps your side vision.3 Scans of the nerve fibers can add detail and catch small changes early. Because you already come in often for injections, your retina team is well placed to fold these checks in. If anything looks borderline, they can compare it against the scans and fields you have had before.
Eye pressure is reported in mmHg, and there is a usual healthy range, with readings above it called ocular hypertension. But no single number tells the whole story. Some eyes tolerate a higher pressure for years with no harm, while others show damage at pressures many people would handle fine. That is why your doctor weighs your pressure together with the look of your optic nerve, your side vision, and your history. Your own baseline and trend matter more than any one reading, so ask what your usual number is and what change would concern your team.
Treating a Pressure Rise and Working as a Team
If a sustained rise does show up, the first treatment is usually straightforward. The most common treatment for higher eye pressure and glaucoma is prescription eye drops that lower the pressure and help protect the optic nerve.3 Most people whose pressure stays up after anti-VEGF injections bring it under control with these pressure-lowering drops, and only a few ever need surgery.1 Drops are used at home on a daily schedule. They do not interfere with your injections, so in most cases you carry on with the retina treatment your eye needs while the drops handle the pressure.
Drops are not the only option, and they are not always enough. When drops do not control the pressure, doctors can use a laser to help fluid drain out of the eye, and surgery is an option if medicines and laser are not enough.3 These steps are the same well-established tools used for glaucoma from any cause. Reaching for them does not mean anything has gone badly wrong; it means your team is matching the treatment to your pressure. The aim throughout is the same: keep the pressure at a safe level so your injections can continue protecting your central vision.
You may find more than one specialist involved, and that is a strength, not a red flag. Your retina specialist manages the injections and watches your pressure at each visit. If the pressure needs ongoing treatment, they often bring in a glaucoma specialist to co-manage the drops or any procedure, while the injections continue. This shared care means one doctor is protecting the back of your eye and another is protecting the optic nerve, with your pressure numbers shared between them. If you see two teams, ask each how they are coordinating so nothing falls through the cracks.
Your Real Risk, the Outlook, and Keeping Your Sight
Put in plain numbers, a lasting pressure problem is the exception, not the rule. In studies of eyes given repeated anti-VEGF injections, a sustained rise in pressure occurred in roughly 5 of every 100, and most of those eyes were managed with pressure-lowering drops.1 In one very large study, about 2 of every 100 people had started a pressure-lowering medicine by two years, and about 3 of every 100 by three years.6 So even after many injections, most people never need pressure treatment at all. Knowing the real size of the risk can take a lot of the fear out of the question.
Yes, gently, and this is the part that speaks to a long treatment history. People who received the most anti-VEGF injections were the most likely to start pressure-lowering treatment, so the risk tends to rise with the total number of shots over time.6 That is why someone at 40 injections has a bit more reason to keep an eye on pressure than someone at their fifth. It is not a reason to stop, though. The vision benefit of the injections is real and ongoing, and the pressure risk is both watchable and treatable, which is a very manageable trade.
The outlook is reassuring when a rise is found and treated in good time. Because your team checks your pressure at frequent injection visits, a rise is usually caught while it is still just a number on a chart, before it has harmed the nerve. Lowering the pressure then protects the optic nerve going forward. The lost ground from untreated high pressure cannot be regained, which is exactly why early, routine checking matters so much. Caught early and treated, a pressure rise from injections is very unlikely to cost you your sight.
When to Call Your Eye Doctor After an Injection
Most soreness after an injection is mild and fades within a day. A few signs are different and should never wait. Call your eye doctor right away, the same day, or go to an emergency room, if after an injection you have any of these:
- Severe or increasing eye pain, or an eye that feels hard and very painful
- A sudden drop or loss of vision
- Increasing redness of the eye, or new and worsening light sensitivity
- A curtain or shadow across your vision, or a shower of new floaters and flashes
After an injection you should promptly report pain, worsening redness, or reduced vision, because these can be signs of a serious eye infection or a large pressure spike that need care right away.4 Acting the same day gives the best chance to protect your sight.
These warning signs matter because two urgent problems can follow an injection, and both are treatable when caught fast. One is a big pressure spike that does not settle. The other is endophthalmitis, an infection inside the eye. A serious infection inside the eye after an injection is rare, happening in fewer than 1 of every 1,000 injections, and it needs urgent treatment.4 Because a painful, red eye with dropping vision can come from either problem, the safe move is always to be seen the same day rather than to guess which one it is.
Not every concern is an emergency, and the everyday protection here is quieter. The single most useful habit is simply keeping your scheduled injection and check-up visits, because that is when your pressure is measured and your optic nerve is watched. If you have noticed a change in your side vision, or you have run out of a pressure-lowering drop, call and ask to be seen soon rather than waiting for the next injection. Steady, on-time monitoring is what turns a possible pressure problem into a caught-early, well-managed one.
Common Questions About Injections and Eye Pressure
They can raise the risk, but for most people they do not. A lasting pressure rise happens in a minority of repeatedly injected eyes, and only some of those need treatment. Having had many injections does put you in the group worth watching a little more closely, since the risk climbs gently with the total number of shots. The reassuring part is that your team checks your pressure at your visits, so a rise would likely be caught early and treated with drops long before it threatened your sight.
Almost immediately, then it usually comes right back down. Adding medicine to the sealed eye makes the pressure spike within minutes. For nearly everyone, that spike is short-lived and drifts back to normal on its own within about half an hour to an hour, without any special treatment. Your doctor may check the pressure or the blood flow at the back of the eye before you leave. It is the pressure that stays up between visits, not this brief spike, that your team is really tracking over the long run.
Usually not, and that is the important catch. A slow, sustained pressure rise typically causes no pain and no change in vision until damage is already done. That silence is exactly why routine pressure checks matter, since you cannot feel the number yourself. The one exception is a very high spike right after an injection, which can make the eye painful, hard, and light-sensitive. That kind of sudden, severe pain is a reason to be seen the same day, but the quiet, symptomless rise is caught by measurement, not by feel.
In most cases, yes. A pressure rise is usually managed with daily pressure-lowering drops that work alongside your injections, so you can keep both going. Only rarely does pressure force a change in the injection plan, and even then your retina and glaucoma doctors weigh it together. Stopping needed injections carries its own real risk to your central vision. The usual path is to treat the pressure and continue the retina care, rather than to choose one over the other. Ask your team how they plan to balance the two.
Generally, yes. Steroid injections and anti-VEGF injections do not affect eye pressure the same way. Steroids act through a separate route, often called a steroid response, and they push the pressure up far more often than anti-VEGF shots do. That is why your doctor treats the two differently and may watch a steroid-treated eye more closely. If you get steroid injections, or a mix of both types, make sure each of your doctors knows, because the steroid is usually the larger pressure concern.
There is no single cutoff that fits everyone. Pressure is measured in mmHg, and there is a usual healthy range, but some eyes are harmed at lower numbers while others tolerate higher ones for years. Your doctor judges your pressure alongside the look of your optic nerve, your side vision, and your own past readings. That is why your personal baseline and trend matter more than any one number. A good question to ask is what your typical pressure runs and what change would prompt them to act.
More Questions About Shots, Pressure, and Glaucoma
They are usually still an option, with extra care. A history of glaucoma or high pressure does raise the chance of a sustained rise from injections, so your team keeps a closer watch on your pressure and may already have you on pressure-lowering treatment. Many people with glaucoma safely receive anti-VEGF injections for a retinal condition. The key is coordination: your retina and glaucoma doctors share your pressure numbers and adjust the drops or plan as needed, so the retina benefit and the nerve protection go hand in hand.
The pressure itself can almost always be brought back down with drops, laser, or surgery. What cannot be undone is optic nerve damage that has already happened from pressure left high too long. That difference is the whole reason for routine checks: catching a rise while it is just a number lets treatment protect the nerve going forward. If a rise is found and lowered in good time, the outlook is good. The lost ground only becomes permanent when a high pressure goes unnoticed and untreated, which monitoring is designed to prevent.
Stopping is very rarely the right move, and it is not a decision to make alone. The conditions these injections treat can steal central vision if left untreated, so quitting to avoid a pressure risk can trade a small, manageable problem for a larger one. A pressure rise is usually handled with drops while the injections continue. If you are worried, talk with your retina specialist rather than skipping appointments, and let them weigh the vision benefit against the pressure risk with your actual numbers in front of them.
Some eye soreness on the day of an injection is normal. What is not normal is severe or increasing eye pain, a hard and very painful eye, a sudden drop in vision, or increasing redness and light sensitivity. A curtain, shadow, or a shower of new floaters and flashes also counts. Any of these calls for same-day care, either a call to your eye doctor or a trip to an emergency room, because they can signal a serious infection or a large pressure spike. Acting quickly gives the best chance to protect your sight.
- What is my usual eye pressure, and what number would concern you?
- Given how many injections I have had, how closely are you watching my pressure?
- Do my optic nerve and side vision look healthy on my recent tests?
- If my pressure rises, would we use drops, and would my injections continue?
- Should a glaucoma specialist be part of my care?
- Which symptoms after an injection should send me in the same day?
- Scientific Reports (PubMed Central, PMC5175276) (2016). Sustained Elevation of Intraocular Pressure Associated with Intravitreal Administration of Anti-vascular Endothelial Growth Factor: A Systematic Review and Meta-Analysis.
- PubMed Central (PMC10578873) (2023). Transient Intraocular Pressure Fluctuations After Intravitreal Bevacizumab Injection in Proliferative Diabetic Retinopathy Patients: A Prospective Study.
- National Eye Institute (NEI) (2024). Glaucoma.
- American Academy of Ophthalmology (2025). Intravitreal Injections (Clinical Statement).
- PubMed Central (PMC10749058) (2023). Incident Glaucoma and Ocular Hypertension After Periocular and Intravitreal Steroid Injections: A Claims-Based Analysis.
- Ophthalmology / American Academy of Ophthalmology (PubMed Central, PMC6698200) (2019). Repeated Intravitreal Injections of Anti-Vascular Endothelial Growth Factors and Risk of Intraocular Pressure Medication Use.